Accium Biosciences entered the industry of Commercial Medical Research in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417110, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Ali Arjomand, President by calling (206) 281-3915 during business hours. You can also write to the business’ Single Location at 550 17th Avenue # 550, Seattle, Washington WA 98122. You can also visit the company’s website at acciumbio.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Accium Biosciences |
Representative: | Ali Arjomand, President |
Place of Business: | 550 17th Avenue # 550, Seattle, WA 98122 |
Contact Number: | (206) 281-3915 |
Website: | acciumbio.com |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 5417110 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2004 |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Accium Biosciences is a company operating from King, Washington providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2004 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 5417110 as Commercial Medical Research.
With a current employee count of 1 to 4, Accium Biosciences has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Ali Arjomand, President at (206) 281-3915 for related queries, or to locate its Single Location using the coordinates 47.60672,-122.31016.
The Single Location can also be found at the street address 550 17th Avenue # 550 in Seattle, Washington 98122 and can be engaged online through the company website at acciumbio.com, the company Twitter , and Facebook page .